Jun 22 0 Bayer-partnered Azitra hopes to apply $7.5M IPO proceeds to near-clinical dermatology pipeline By Cain | Featured
Oct 12 0 ‘Pluck those diamonds’: Bayer’s Vividion eyes up to nine oncology targets from Duke spinout By Cain | Featured
Recent Comments